Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in ...

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

Ozempic and other GLP-1 drugs are now being recommended by a top health organization in a major shift on how a chronic ...

As people’s bodies change because of GLP-1s, so does their spending across industries including fashion, restaurants, gyms ...

The next-generation “GLP-1 plus” drugs will be tailored to the health needs of individual patients.

And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new wave of next-level GLP-1 treatments, with several promising candidates in the pipeline. These experimental ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...

Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...